Angle Share Discussion Threads

[tbow112] 21/12/2024 12:06

What a pair of idiots ! They cant even read a one sentence question !

[htrocka2] 21/12/2024 10:45

All you had to do was to post the request to Google...

[muffster] 21/12/2024 09:42

Find out yourself

[tbow112] 21/12/2024 08:26

Anyone know how long it takes to get approval for a drug trial in the UK or USA ?

[yasx] 20/12/2024 16:32

Bones,

If AZ give the go ahead I think that will prove transformational since a trial would be the gateway to potentially be utilised in many more so revenues growth could be exponential. The nod from AZ also provides evidence of a demand for AGL’s offering.


We also can’t rule out Eisai and potentially others. AGL need time and money but to enable that they crucially need AZ to proceed fairly soon to enable them to get the business miving.

[bones698] 20/12/2024 16:25

Yas you can try all you like but many on here don't like to listen, then get all bitter and twisted because they didn't see the signs and end up sat on big losses . Only themselves to blame . Some border on delusional .

For me even if they get the AZ deal it's only 1-3m from ANs mouth and so won't fill the gaping hole in revenues . That will mean another fund raise around march otherwise results won't get signed off again . Either way unless they come up with some amazing new news to get the share price up it will be another discounted placing imo. With the amount they will require I just don't see much good news in the near future that won't get wiped out by the placing . Might aswell watch things unfold and not get caught out like so many ha e here over the years .

[yasx] 20/12/2024 15:36

Goosed,

Whatever I do or don’t recall is one thing and not particularly relevant - but the inescapable conclusion is that thus far revenues generated to date are anaemic and AN does mot have sufficient time or funds to wait on AZ for months. Unless the Co provides a formal update soon that AZ are proceeding to the next phase then it looks rather grim for AGL and attendance at a two bit event in India does not alter that.

[atmysignal] 20/12/2024 14:22

I think I'll continue to take my information from announcements through RNS rather than listen to someone like you, an anonymous poster on a bulletin board, "think". You couldn't make it up!Thanks for your concern.

[gooosed] 20/12/2024 12:02

yasX - from your 26834

"and I think I recall AN mentioningbthis although I have as yet been unable to provide evidence of that."

You "think" you recall but can't be sure. You still have not been able to provide a link to confirm whether or not you were mistaken in that recollection. Should we assume that while posting negative replies about a perfectly valid trade mission, that you've been unable to validate your thinking & have given up ?

Wishing all a very Merry Xmas & safe travels to visit friends & family during the festive season.

[atmysignal] 20/12/2024 10:43

Yasx crewClock is tickingPost count increasing Last go before they cover their shorts and move on.

[yasx] 20/12/2024 10:06

Two words: Abingdon Health.

Best of the best.

Oh dear.

[5oletrader] 19/12/2024 23:58

Shhh https://www.gov.uk/government/groups/healthcare-uk• Healthcare UK's headquarters are in London. It works with the DBT's (Department for Business and Trade) network of advisers located in more than 100 countries.+To attend - companies 'had' to make an "APPLICATION".• Obviously the UK government was willing to approve applications from "any ol' tin pot company" willing to pay just '£200 to stay in sub standard hotels' - and only 13 companies could be bothered - give me strength -Let's 'ignore' Healthcare UK were seeking "THE BEST" of British healthcare innovators who are well prepared to scale up outside the UK, to join the mission to INDIA.

[yasx] 19/12/2024 23:29

To put that event into some sort of context, one of the other 13 Co’s to which ST refers is none other than aim tiddler Abingdon Health. The price of its shares resemble the chart of Angle, falling from 130p in 2021 to the current 7p.

Attending that event is of nil significance. That ST sought to suggest it was is indicative of his desperation to talk this up.

Bermuda offers salient points to consider but ST and those of his ilk are utterly clueless.

[yasx] 19/12/2024 23:13

Incidentally, it was hardly an event requiring “selectionR17; - a ten second google search reveals the poster pitching for Co’s to attend for a fee of £200 and a stay at sub standard hotels!

Poor ST simply cut and paste excerpts from the poster portraying it as a unique insight as a result of his extensive research. Give me strength.

hxxps://www.bivda.org.uk/Portals/0/documents/Export/UK-India%20Healthcare%20Trade%20Mission%202024%20Flyer%20R05.pdf?ver=CGAlN7JJIAaZm8hSGzLvpQ%3D%3D#:~:text=Healthcare%20UK%2C%20part%20of%20the,over%20the%20last%20eight%20years.

[yasx] 19/12/2024 23:05

ST needs help - perhaps there might be a cure for the syndrome he has.

So apparently AGL are attending some event in India. Jolly good. A bit like a tinpot mining explo Co with not a single ounce of resource talking about a multi billion commodity market it has the potential to exploit.

Angle need to drive up revenues fairly soon or existing holders will be diluted into oblivion. It is as simple as that, no matter how others try to dress it up.

[washingmachine] 19/12/2024 21:55

Actually no it doesn’t
They have over 20 million PA overheads
And after 2 decades
Not coming any were near to covering it.
I’m convinced other than bespoke areas, it’s not being taken up
Still no one answered
Were did the Solaris trial go ?
Which was significant at the time
You can bury your head all you want
The share price is at near all time low

[5oletrader] 19/12/2024 21:49

Yeh because AGL are a bunch of 'mugs' (to quote one of the crew). And yasX displaying ADW198 traits-That's why AGL were ONE of the 13 British Healthcare Companies invited as part of a UK GOVERNMENT DELEGATION to attend the "UK-INDIA Healthcare Trade Mission 2024"Interestingly...• INDIA is among the FASTEST GROWING health ECONOMIES in the WORLD and among the top 3 healthcare markets in terms of incremental growth to reach $638BILLION by 2025.• INDIA is the LARGEST EXPORT MARKET for UK medical goods worth over $150MILLION across high tech medical imaging equipment, instruments, implants and consumables.https://www.bivda.org.uk/Portals/0/documents/Export/UK-India%20Healthcare%20Trade%20Mission%202024%20Flyer%20R05.pdf?ver=CGAlN7JJIAaZm8hSGzLvpQ%3D%3D-A UK delegation, comprising 13 British healthcare companies covering MEDICAL TECHNOLOGY, clinical services, digital health and AI.• The aim of the mission is to create a lasting impact on the health and well-being of the citizens of "BOTH" the UK and INDIA, to "TRANSFORM" the healthcare landscape in both countries and "SERVE AS A MODEL" for international cooperation in healthcare.https://health.economictimes.indiatimes.com/amp/news/industry/13-british-healthcare-companies-take-part-in-10th-uk-india-healthcare-trade-mission/115718813-Pleased to see AGL rubbing shoulders with high profile people listed here:• Sir Stephen POWIS - National Medical Director - NHS EnglandWho said:"The 10th edition of the UK Healthcare Trade Mission to INDIA and to bring with us a delegation of UK healthcare organisations, all of whom have been selected to represent the UK's WORLD-CLASS CAPABILITIES in healthcare innovation across the next generation of digital, MED-TECH, and education and training.""So the UK companies that we have brought today bring a range of expertise in all these areas. They are LOOKING for PARTNERSHIPS with LEADING INDIAN HOSPITALS and HEALTHCARE PROVIDERS and with TECH COMPANIES to spread innovation to benefit patients in INDIA"https://www.england.nhs.uk/about/nhs-england-board/our-leadership-team/• Mr. Harjinder KANG - His Majesty's Trade Commissionerhttps://www.gov.uk/government/people/harjinder-kang• Anna SHOTBOLT - Deputy Trade Commissioner for South Asiahttps://www.gov.uk/government/people/anna-shotbolt#:~:text=Anna%20Shotbolt%20was%20appointed%20Deputy,Kerala%20appointed%20in%20January%202022.• Ms. Halima HOLLAND - Deputy High Commissioner to Chennaihttps://www.gov.uk/government/people/halima-holland#:~:text=Role-,Biography,Middle%20East%20and%20South%20Asia.-Some extra 'stuff' for the brain to ponder..."India's Potential as a Leader in Cancer Care Progress in the Future"https://pmc.ncbi.nlm.nih.gov/articles/PMC11457899/Notice...• INDIA finds itself at a "TRANSFORMATIVE" crossroads in its healthcare evolution, with CANCER care emerging as a critical frontier for innovation and progress.• INDIAs PHARMA SECTOR, renowned globally as the "pharmacy of the world," is a testament to the nation's formidable prowess in drug innovation, large-scale manufacturing, and global distribution networks. This powerhouse industry underscores India's DOMINANCE in the PHARMA landscape and highlights its pivotal role in ensuring global access to life-saving medications.• The "CLINICAL TRIAL LANDSCAPE" is evolving, with regulatory reforms making INDIA an ATTRACTIVE destination for "GLOBAL STUDIES"• INDIA remains "UNDERREPRESENTED" in GLOBAL "CLINICAL TRIALS"• The country's GENOMIC databases are still in their "INFANCY"• INDIA is on the "CUSP" of a healthcare TRANSFORMATION that could "REDEFINE" the landscape of PRECISION ONCOLOGY on a "GLOBAL" scale-Obviously all the above means absolutely nothing? :-)

[yasx] 19/12/2024 21:20

Bermuda,

Thank you for your input which is helpful. One other aspect to consider is that if AZ is a long way off from the next stage if it indeed does proceed (and in the absence of additional deals with other Co’s), where will the revenue come from to prevent another raise in 25? We have Eisai but itvreally needs one or two new deals to spread the risk and broaden income streams.

They did not get close to the last forecast of revenues of 6.4M and without an exponential increase in activity soon they won’t achieve anything like that next year either.

Papers, presentations and studies are a necessary concomitant to support the efficacy of Angle’s offering, but soon AN needs to demonstrate by way of increased revenues that there is both a need and demand for it. As of now that is questionable.

[kryptonsnake] 19/12/2024 19:49

Thanks for your wisdom Willfy

Last time you posted here was September 2023

"Unless a big deal is announced before end of year, next large fund raise will be 5p plus with massive dilution"

No massive dilution at 5p. You clearly lack judgement and intelligence



sent from my iPhone

[bermudashorts] 19/12/2024 17:28

yasX,

Completely honest answer is that I have no idea and without being privy to AZN's R&D strategy for its pipeline I wouldn't even be able to make a reasonable judgement call. Even if AZN have a trial in mind, it can take months to set up and get regulatory clearance to start a clinical trial so am taking the Company at its word that progress with development of the assay has been encouraging and that all is on track.

If it helps, the time for having the sort of debate bones is suggesting is if AZN start any new phase 2 or 3 trials targeting the DDR pathway, including combination trials (but excluding adjuvant and neoadjuvant setting) without any update from Angle.

By the way, it's also worth watching for any trial results from Artios Pharma. As you probably know, they also commissioned a bespoke DDR assay from Angle and their trial results may give some indication of how useful it proved to be in the clinic.

[seball] 19/12/2024 17:13

Bermudashorts thanks for taking time to post

[washingmachine] 19/12/2024 16:57

What happened to the Solaris trial ?

[zeus19] 19/12/2024 16:43

Martyns back! Grade A w%*ker